_edited.jpg){kind=small}
_edited.jpg){kind=small}
Enclomiphene is a medication commonly prescribed to help treat infertility and raise testosterone levels in men. This patient guide discusses the benefits of enclomiphene, how it works, and situations where it should not be used.
Enclomiphene is a medication that has garnered significant attention in recent years for its potential applications in the treatment of male infertility and hypogonadism. While it has yet to receive FDA approval, numerous studies have demonstrated promising results, making it a topic of interest for patients and healthcare professionals. In this comprehensive patient guide, we will explore the benefits of enclomiphene, how it works, when it shouldn't be used, and important considerations when seeking treatment.
How is enclomiphene different from clomiphene?
Enclomiphene and clomiphene are closely related drugs, but they have some key differences in their composition and mechanisms of action. Clomiphene is a mixture of two isomers: enclomiphene and zuclomiphene. Enclomiphene is the more active isomer, responsible for most of clomiphene's therapeutic effects, while zuclomiphene is less active and may contribute to some of the side effects experienced by users [1].
Enclomiphene is a more purified form of clomiphene, containing only the enclomiphene isomer. This selective composition results in a medication with fewer side effects and potentially increased efficacy. While clomiphene has long been used in fertility treatments for women, enclomiphene is being studied primarily for its applications in treating male infertility and hypogonadism.
Benefits of Enclomiphene
Enclomiphene has several potential benefits for patients, including:
a) Improved Testosterone Levels: Enclomiphene acts by boosting the production of gonadotropin-releasing hormone (GnRH) in the hypothalamus, which causes the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones subsequently encourage the creation of testosterone in the testes, resulting in higher testosterone levels.
b) Preservation of Fertility: Unlike traditional testosterone replacement therapy (TRT), enclomiphene does not suppress the production of sperm, making it a more attractive option for men who wish to preserve their fertility [2].
c) Fewer Side Effects: As mentioned earlier, enclomiphene's selective composition results in a medication with fewer side effects compared to clomiphene. The reduced presence of the zuclomiphene isomer decreases the likelihood of experiencing side effects such as mood swings, hot flashes, and vision disturbances.
When Enclomiphene Should Not Be Used
Enclomiphene is not suitable for all patients, and there are certain circumstances in which it should not be used:
a) Female Patients: Enclomiphene is not intended for female patients, as its primary applications are in treating male infertility and hypogonadism.
b) Prostate Cancer: Men with a history of prostate cancer or an elevated risk for the disease should avoid enclomiphene, as it may stimulate testosterone production and exacerbate the condition.
c) Liver Disease: Patients with severe liver disease should not use enclomiphene, as the medication is metabolized by the liver and could worsen liver function.
Be wary of clinics that only offer one treatment medication.
When seeking treatment for infertility or hypogonadism, it's essential to choose a healthcare provider that offers a comprehensive range of treatment options. A clinic that only offers one medication may not be able to effectively manage side effects or adjust therapy to achieve the best results.
For instance, some patients on enclomiphene may require the addition of an aromatase inhibitor, such as Arimidex, to manage estrogen levels. A clinic that does not offer multiple treatment options may not be able to effectively address this need, which could negatively alter treatment outcomes.
It's also important to consider the experience and expertise of the healthcare provider. A knowledgeable and experienced professional will be better equipped to make informed decisions about the most appropriate course of treatment and handle any potential complications.
Enclomiphene Dosing
Enclomiphene dosing is typically individualized, with the dosage adjusted based on the patient's response to treatment. Initial dosing often begins at a low level, such as 12.5 to 25 mg per day, with the dose gradually increasing if necessary [3]. Monitoring testosterone levels, estrogen levels, and other relevant hormone markers is crucial during treatment to ensure optimal results and minimize side effects.
As enclomiphene is not yet FDA-approved, it is essential to work closely with a knowledgeable and experienced healthcare provider who can guide you through the dosing process and make necessary adjustments based on your specific needs.
Enclomiphene and FDA Approval
There are several reasons why the FDA has not approved enclomiphene citrate for the treatment of secondary hypogonadism, despite the evidence suggesting potential benefits:
Insufficient evidence: In 2007, when enclomiphene citrate was first evaluated, the FDA did not regard the increase in testosterone levels as sufficient evidence to support a non-testosterone treatment for hypogonadism.[4].
Side effects: Clomiphene citrate, which is a mixture of enclomiphene and zuclomiphene, has been associated with side effects such as mood changes, blurred vision, breast tenderness, weight gain, and venous thromboembolism (VTE). While enclomiphene may not cause the same side effects due to its shorter half-life and different pharmacological properties, this has not been proven in hypogonadal men.
Limited applicability: Clomiphene citrate and enclomiphene citrate require a functional hypothalamic-pituitary-gonadal (HPG) axis to be effective and cannot be used in men with organic hypogonadism [5].
Incomplete response: In 10% of patients treated with clomiphene citrate, sexual symptoms did not improve. It is unclear whether enclomiphene citrate would yield better results in this regard [6].
Lack of comparative studies: While some experiments have found differences in the pharmacological properties and side effects between enclomiphene, zuclomiphene, and clomiphene citrate, there is a lack of direct comparative studies in hypogonadal men to establish the superiority of enclomiphene citrate over clomiphene citrate or other treatments [7].
Enclomiphene represents a promising treatment option for male infertility and hypogonadism, with potential benefits such as improved testosterone levels, preservation of fertility, and fewer side effects compared to clomiphene. However, it is essential for patients to be aware of the circumstances in which enclomiphene should not be used and to be cautious when selecting a healthcare provider for their treatment.
While enclomiphene is not yet FDA-approved, ongoing research may eventually lead to its approval and broader availability. In the meantime, patients should work closely with an experienced and knowledgeable healthcare provider to arrive at the most appropriate treatment option based on their individual needs and circumstances.
If you're considering enclomiphene as a treatment option for male infertility or hypogonadism, it's crucial to choose a healthcare provider with expertise in this area. Regenx Health is dedicated to providing cutting-edge treatments, including enclomiphene, for men seeking help with fertility and hormonal issues.
At Regenx Health, our experienced and knowledgeable team will work closely with you to determine the most feasible treatment plan based on your individual needs and circumstances. We prioritize patient education and ensure you have a comprehensive understanding of enclomiphene, its benefits, and any potential risks.
Don't wait any longer to take control of your health and explore your treatment options. Visit Regenx Health today to learn more about our services, and schedule a consultation with one of our specialists. Together, we can help you effectuate your goals and improve your quality of life.